Nonetheless, all these conditions were associated with a statistically significant, or near-significant, reduction in progression-free survival (PFS) compared to the control (unaltered) group (Fig. 5 B).
← all excerpts
Proinflammatory macrophage secretome enhances temozolomide sensitivity in glioblastoma via pSTAT3-mediated downregulation of DNA repair enzymes.
1
—
—